Chicago, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Clinical Trials Market is projected to reach USD 52.0 billion by 2026 from USD 38.7 billion in 2021, at a CAGR of 6.1% during the forecast period, according to a new report by MarketsandMarkets™. The drug discovery process is complex, particularly in the clinical stage. Conducting clinical trials is both risk and resource-intensive, which necessitates maintaining a balance for executing each clinical trial stage correctly. This is expected to propel the demand for outsourcing clinical trial services, in turn driving the clinical trials market growth. On the other hand, shortage of skilled professionals and meeting the need of providing unique analytical testing approach may challenge market growth to a certain extent.
Browse in-depth TOC on "Clinical Trials Market"
324 - Tables
59 - Figures
304 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=405
List of Key Players:
- IQVIA (US),
- LabCorp (US),
- Charles River Laboratories (US),
- WuXi AppTec (China),
- Syneos Health (US),
- PPD (US), and
- ICON Plc (US).
Clinical Trails Market Dynamics:
- Driver: Increasing investment in pharmaceutical R&D
- Challenges: Requirement of unique analytical testing approaches for innovative drug molecules
- Opportunity: Need for novel clinical trial designs for complex cell and gene therapies
Based on phase, the clinical trial market is segmented into phases I, II, III, and IV. Phase III dominated the market in 2020. Services that incur high expenses and large patient/population size are the key factors attributing to the high share of the Phase III segment.
Based on service type, the clinical trials market is segmented into protocol designing, site identification, patient recruitment, laboratory services, bioanalytical testing, analytical testing, clinical trial supply & logistic services, decentralized clinical services, clinical trial data management services, medical device testing services, and other services. Laboratory services is the leading segment of clinical trial services market, this can be attributed to the increasing preference of clinical research professionals to outsource such services. Among all the aspects of conducting clinical trials (such as protocol designing, site identification, and patient recruitment, among others), laboratory services have witnessed comparatively high outsourcing rates in the past few years, thus contributing to the growth of this segment.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=405
Based on the therapy area, the clinical trials market is segmented into oncology, infectious diseases, cardiology, neurology, women's health, genetic diseases, immunology, and other therapeutic areas. The large share of oncology segment is primarily attributed to the increasing number of drug discovery activities for oncology and the rising prevalence of cancer worldwide.
The clinical trials market is segmented into small molecules, vaccines, cell & gene therapy, and others based on application. Small molecules is the key driver of the clinical trials application market, regardless of the synthetic method and materials used, small molecules are able to retain their chemical identity as opposed to sensitive biologics candidates, which has contributed to the robust demand for small molecule drug candidates. The majority of the patented drugs marketed in the past five years have been small molecules and generics of these patented drugs.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=405
Geographical Growth Scenario:
The clinical trials market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East and Africa (MEA). In 2020, North America accounted for the largest share of the clinical trial market, followed by Europe. The large share of the North American regional segment can be attributed to presence of a well-established base of pharmaceutical & biopharmaceutical companies, and high investments in the biosimilars & biologics market space.
Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting
Browse Related Reports:
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines), End User - Global Forecast (2022 - 2027)
Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) - Global Forecasts to (2022 - 2025)
